voriconazole

Manufacturer:
Misc
Route of Administration: 
Oral, Intravenous
Site of Care:
Outpatient
Website: 
    Enrollment Forms:
    Synergen Prescription Form

    Approved Indication:

    • treatment of invasive aspergillosis
    • treatment of Candidemia in nonneutropenic patients and the following Candida infections: disseminated infections in skin and infections in abdomen, kidney, bladder wall, and wounds
    • treatment of esophageal candidiasis
    • treatment of serious fungal infections caused by Scedosporium apiospermum and Fusium spp. in patients intolerant of or refractory to other therapy

    Conditions:

    • Aspergillosis
    • Candidiasis

    Therapeutic Area:

    • Infectious Disease